Literature DB >> 2670992

Modern high-performance liquid chromatographic-radioimmunoassay strategies for the study of eicosanoids in biological samples.

E Gelpí1, I Ramis, G Hotter, G Bioque, O Bulbena, J Roselló.   

Abstract

An evaluation of the most recent literature on the determination of eicosanoids by immunoassay methods confirms that owing to the inherent lack of specificity of many of the antibodies used for this purpose, immunological assays (radioimmunoassay or enzyme immunoassay) are often preceded by solid-phase extraction followed by further purification of the antigens of interest by routine reversed-phase high-performance liquid chromatographic methods. In this way the analytical potential of radioimmunoassay is remarkably enhanced and accuracy and precision of the assay are ensured.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670992     DOI: 10.1016/s0378-4347(00)84470-9

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.

Authors:  X Bertrán; J Mañé; F Fernández-Bañares; E Castellá; R Bartolí; I Ojanguren; M Esteve; M A Gassull
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

2.  Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour.

Authors:  A Cárdenas; H Roels; A M Bernard; R Barbon; J P Buchet; R R Lauwerys; J Roselló; G Hotter; A Mutti; I Franchini
Journal:  Br J Ind Med       Date:  1993-01

3.  Prostanoids and oxygen free radicals in early stages of experimental acute pancreatitis.

Authors:  D Closa; G Hotter; J Rosello-Catafau; O Bulbena; L Fernandez-Cruz; E Gelpi
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

4.  Prostanoid generation in early stages of acute pancreatitis: a role for nitric oxide.

Authors:  D Closa; G Hotter; N Prats; O Bulbena; J Roselló-Catafau; L Fernández-Cruz; E Gelpí
Journal:  Inflammation       Date:  1994-10       Impact factor: 4.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.